Sign inGet started

Seltzer Stacey Denenberg

Insider CIK 1648895 · AIMT Director · RPHM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RPHM Reneo Pharmaceuticals, Inc A Award deriv2023-06-062023-06-0817,500— $017,500SEC↗
RPHM Reneo Pharmaceuticals, Inc A Award deriv2022-06-012022-06-0317,500— $017,500SEC↗
RPHM Reneo Pharmaceuticals, Inc A Award deriv2021-04-082021-04-1214,000— $014,000SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1415,398$17.39 $267.8K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1411,432$14.60 $166.9K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-147,500$1.71 $12.8K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1419,755$19.10 $377.3K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1417,500$16.24 $284.2K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1452,421$28.21 $1.48M0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer2020-10-132020-10-147,840$34.50 $270.5K0SEC↗
AIMT Aimmune Therapeutics, Inc. U Tender2020-10-102020-10-1410,221$34.50 $352.6K0SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2020-05-272020-05-2915,398— $015,398SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2020-05-272020-05-297,840— $018,061SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2019-05-232019-05-2811,432— $011,432SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2019-05-232019-05-286,442— $010,221SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2018-05-232018-05-247,500— $07,500SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2018-05-232018-05-243,750— $03,779SEC↗
AIMT Aimmune Therapeutics, Inc. J Other2017-12-062017-12-0829— $029SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2017-05-252017-05-3017,500— $017,500SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2016-05-252016-05-2719,755— $019,755SEC↗